CTA Array

Product Number 33000

Pricing

CodeProduct Description
33000CTA Array Kit

Description

KREX™-based protein array for high-throughput quantification of autoantibodies to Cancer-Testis (CT) antigens. CT antigens are a group of unrelated proteins that show highly restricted expression profiles in adult somatic tissues but which are aberrantly expressed in various cancers.

Key applications:

  1. Unique differential profiling of cancer-antigen in various cancer types
  2. Patient stratification in checkpoint inhibitor studies
  3. Determination of epitope recognition in patients or monitor patients in experimental cancer vaccine studies

Specifications

Product name: CTA Array

Minimum Order : 5 slides

Slide Type: Streptavidin-coated glass slide

Species: Human

Storage: Store for up to 12 months at -20°c

Delivery lead time: 4 weeks

SUPPORT

Resources to access our technology

FAQs

Your technical questions - answered

APPLICATIONS

One technology - endless possibilities

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a Functional Proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREX can also be used to identify autoantibody biomarkers to diagnose cancer, autoimmune, neurodegenerative or infectious diseases with higher sensitivity and specificity than conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics UK Ltd. Registered in England and Wales no. 12889389 | Sengenics Corporation Pte. Ltd. Registered in Singapore no. 201734100D